Rajasthan: Banned Chemical For MD Seized, Smuggler Held
During the operation, police seized 7.387 kg of banned chemical powder, 2-Bromo-4-methylpropiophenone, a key precursor used in the manufacture of MD (Mephedrone), along with 5 grams of the finished drug.
The total estimated value of the seized material in the international market is approximately Rs 5.60 crore.
Superintendent of Police Aditya stated that, acting on specific intelligence and under the guidance of Additional Superintendent of Police Gajendra Singh Jodha and Circle Officer Chandrashekhar Paliwal, police learned that Abid Khan, a resident of Naungawa, was allegedly manufacturing MD near a well on his farmland with the help of family members.
Acting swiftly, teams led by Arnod Station House Officer Shivlal Meena and District Special Team In-charge Pratap Singh conducted a joint raid.
During the search operation, a sack containing a shiny banned chemical powder was recovered. It had been concealed under foliage near a water tank adjacent to the well.
A small packet of prepared MD was also recovered nearby. The seizure is particularly significant as the Government of India, through a Gazette Notification dated March 11, 2026, recently brought 2-Bromo-4-methylpropiophenone under the provisions of the Narcotic Drugs and Psychotropic Substances Act.
This marks the first recorded seizure of this newly banned chemical in Pratapgarh district, making the operation a notable breakthrough for local law enforcement.
Police arrested the accused, Abid Khan, on the spot and registered a case under relevant sections of the Narcotic Drugs and Psychotropic Substances Act.
Authorities are now investigating the source of the chemical and probing the intended supply network, including the states or cities where the manufactured MD is likely to have been distributed.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment